Skip to main content
RT @healthhashtags: Top Influencers of #RNL2022: @doctorRBC @hausmannMD @RheumNow @uptoTate @NoufAhmedAlham2 @Janetbirdo

Symplur Hashtags healthhashtags

4 years 6 months ago
Top Influencers of #RNL2022: @doctorRBC @hausmannMD @RheumNow @uptoTate @NoufAhmedAlham2 @Janetbirdope More 📊 https://t.co/5tIzMLfqrh
RT @uptoTate: Dr. Kavanaugh reviews the process of guidelines/recommendations. It's a lot of work! #RNL2022 @RWCSmtg @Rh

Dr. Rachel Tate uptoTate

4 years 6 months ago
Dr. Kavanaugh reviews the process of guidelines/recommendations. It's a lot of work! #RNL2022 @RWCSmtg @RheumNow https://t.co/z48mVKweVq
POD 3 on Psoriatic Arthritis Advances will begin at 2pm ET and Dr. Artie Kavanaugh will lead the first presentation of t

Dr. John Cush RheumNow

4 years 6 months ago
POD 3 on Psoriatic Arthritis Advances will begin at 2pm ET and Dr. Artie Kavanaugh will lead the first presentation of the pod titled PsA Guidelines: The Good, Bad & Ugly. #RNL2022 https://t.co/cx3XBSWbNr
RT @madanpadmajan1: Anifrolumab high incidence of herpes zoster #RNL2022
4 years 6 months ago
Anifrolumab high incidence of herpes zoster #RNL2022
RT @uptoTate: Dr. Narain: SLE flare risk w/ HCQ tapering/reducing dose vs maintaining.
Retinopathy risk:
💎doubles eve

Dr. Rachel Tate uptoTate

4 years 6 months ago
Dr. Narain: SLE flare risk w/ HCQ tapering/reducing dose vs maintaining. Retinopathy risk: 💎doubles every 5 yrs of use 💎^ w/ ^ dosing per ABW 💎^ w/ IBW in dose-response manner 💎independent risk factors: cumulative HCQ use, duration of use, CKD, Asian decent #RNL2022 @RheumNow https://t.co/lgMNEmQEhl
RT @doctorRBC: Interesting potential upcoming SLE treatments
Data from China
Improvement of SRI-4 response rate compared

Robert B Chao, MD doctorRBC

4 years 6 months ago
Interesting potential upcoming SLE treatments Data from China Improvement of SRI-4 response rate compared to placebo @RheumNow #RNL2022 https://t.co/VE5Tza7xt8
RT @NoufAhmedAlham2: Anifrolumab and lupus.

Don not forget Herpes zoster vaccination!!

Sonail Narain @RheumNow #Rnl202

Nouf Al hemmadi NoufAhmedAlham2

4 years 6 months ago
Anifrolumab and lupus. Don not forget Herpes zoster vaccination!! Sonail Narain @RheumNow #Rnl2022 https://t.co/hNWaSHH27d
RT @Janetbirdope: #ClinicalPearl Maybe..2 approaches that may Rx #SLE. More data needed but restoring IL2 or use of Teli

Janet Pope Janetbirdope

4 years 6 months ago
#ClinicalPearl Maybe..2 approaches that may Rx #SLE. More data needed but restoring IL2 or use of Telitacept latter w BLyS & APRIL effects (B cell signalling) #RNL2022 @RheumNow https://t.co/qjHZH9Xg0k
RT @NoufAhmedAlham2: Great talk by Sonail Narain at #Rnl2022 @RheumNow
Take home message!! https://t.co/rT8WNPRtvB

Nouf Al hemmadi NoufAhmedAlham2

4 years 6 months ago
Great talk by Sonail Narain at #Rnl2022 @RheumNow Take home message!! https://t.co/rT8WNPRtvB
RT @NoufAhmedAlham2: Targeting the BLyS-APRIL signaling pathway in SLE
Sonail Narain @RheumNow #Rnl2022 https://t.co/g3M

Nouf Al hemmadi NoufAhmedAlham2

4 years 6 months ago
Targeting the BLyS-APRIL signaling pathway in SLE Sonail Narain @RheumNow #Rnl2022 https://t.co/g3MbO4swKy
RT @doctorRBC: Role of Anti-CD-19 CAR-T therapy in treatment of refractory SLE?

Case reports only thus far
@RheumNow #R

Robert B Chao, MD doctorRBC

4 years 6 months ago
Role of Anti-CD-19 CAR-T therapy in treatment of refractory SLE? Case reports only thus far @RheumNow #RNL2022 https://t.co/0dIid7viZ5
RT @RumorDoc: “Physician global impression on RA control changes DMARD prescription, while patient global changes DMAR

Ara Dikranian RumorDoc

4 years 6 months ago
“Physician global impression on RA control changes DMARD prescription, while patient global changes DMARD adherence” —Dr. Michaud #RNL2022
RT @doctorRBC: Emphasizing what we should know. Do not stop or decrease HCQ - associated with SLE flares

@RheumNow #RNL

Robert B Chao, MD doctorRBC

4 years 6 months ago
Emphasizing what we should know. Do not stop or decrease HCQ - associated with SLE flares @RheumNow #RNL2022 https://t.co/ko37cBOQPF
Great presentation by Dr. Narain on Novel Treatment of SLE #RNL2022 https://t.co/l9LyH1oPhd

Dr. John Cush RheumNow

4 years 6 months ago
Great presentation by Dr. Narain on Novel Treatment of SLE #RNL2022 https://t.co/l9LyH1oPhd
×